relapse.
The median time to achieve 500 neutrophils/ LL or The NBMC concentration was adjusted to 2 x l0 cells/mL. A lumbar puncture with injection of methotrexate (MTX) (10 mg/m2 not exceeding 12 mg) was performed before initiation of the preparative regimen.
Fifteen patients received a preparative regimen of busulfan (Bu), 1 mg/kg orally every six hours) on days -9, -8, -7, and -6 followed by cyclophosphamide (CYC, 50 mg/kg intravenously [IV]) on days -5, -4, -3, and -2.
UPN 13 received four infusions of cytosine arabinoside (Ara-C), 3 g/m2 every I 2 hours for two days) after CYC administration because marrow blasts were still detected after completion of Bu/CYC. Two patients in early relapse (UPN 39 and 71) received a preparative regimen containing Bu (1 mg/kg orally every six hours) for four days followed by CYC (60 mg/kg IV) and Ara-C (2 g/m2 IV every I 2 hours) on days -3 and -2. Bone marrow was infused on day 0.
With one exception (UPN 57 received the Bu/CYC regimen), patients with previous or active meningeal leukemia and one patient with leukemia cutis were treated with CYC (50 mg/kg IV) on days -8, -7, -6, and -5 and total body irradiation (TBI) 3 Gy daily with lungs shielded after 9 Gy on days -4, -3, -2, and -1. The CYC-TBI regimen was selected for patients with meningeal leukemia since the penetration of BU into the cerebrospinal was not known when the study was initiated. ' required to achieve an absolute neutrophil count (ANC) of 50O/ L ( Fig 1A) or 1,000 leukocytes/ L. A platelet count of 20,000/ zL and 50,000/zL (Fig 1 B) 
